Table 2.

Mφ cytostatic activity triggered by LPS during acute GVHD

Treatment in vitroProliferation of MDW4 targets cocultured with Mφ, %
NormalAcute GVHDSyngeneic
Medium 83.1 ± 1.3 82.4 ± 5.0 86.4 ± 1.2 
LPS 2.5 ng/mL 80.9 ± 3.1 0.5 ± 0.1 82.9 ± 3.1 
LPS 2.5 ng/mL + IFN-γ 1.7 ± 0.1 0.6 ± 0.3 1.3 ± 0.9  
LPS 2.5 ng/mL + IFN-γ + anti–IFN-γ 83.0 ± 8.6 3.8 ± 0.9 87.1 ± 4.2  
LPS 2.5 ng/mL + anti–IFN-γ 89.4 ± 4.9 5.6 ± 3.4 82.3 ± 3.7 
Treatment in vitroProliferation of MDW4 targets cocultured with Mφ, %
NormalAcute GVHDSyngeneic
Medium 83.1 ± 1.3 82.4 ± 5.0 86.4 ± 1.2 
LPS 2.5 ng/mL 80.9 ± 3.1 0.5 ± 0.1 82.9 ± 3.1 
LPS 2.5 ng/mL + IFN-γ 1.7 ± 0.1 0.6 ± 0.3 1.3 ± 0.9  
LPS 2.5 ng/mL + IFN-γ + anti–IFN-γ 83.0 ± 8.6 3.8 ± 0.9 87.1 ± 4.2  
LPS 2.5 ng/mL + anti–IFN-γ 89.4 ± 4.9 5.6 ± 3.4 82.3 ± 3.7 

Proliferation was calculated from 48-hour cultures of Mφ plus targets, Mφ alone, or target cells alone and expressed as the percent incorporation of [3H]TdR as follows: [(cpm Mφ + target)/[(cpm Mφ) + (cpm target)]] × 100. Acute GVHD animals were transplanted with 60 × 106 B6 cells, and syngeneic animals were transplanted with 60 × 106B6AF1 cells. Mφ were isolated on day 14 posttransplantation. Data are presented as mean ± SEM of 3 experiments. The cpm of target cells cultured in medium or medium containing 2.5 ng/mL LPS was 355 ± 19 and 359 ± 13 (×10−3), respectively.

Close Modal

or Create an Account

Close Modal
Close Modal